1 not yet recruiting, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Unknown 1 |
Follow recombinant human endostatin adenovirus: new trials by email Literature Review of recombinant human endostatin adenovirus trials Research Report on recombinant human endostatin adenovirus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Endostatin Adenovirus With Checkpoint Inhibitor in Advanced Head and Neck or Esophageal Cancer recombinant human endostatin adenovirus, PD-1 Inhibitor - Esophageal Cancer, Head and Neck Cancer (H&Amp;Amp;Amp;N) | Phase 1 | Not yet recruiting | Sichuan University | 40 | 2025-09-01 | 2025-09-04 |
| Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors recombinant human endostatin adenovirus, Cisplatin injection, Paclitaxel injection - Head and Neck Neoplasms | Phase 2 | Unknown | Renmiao Zhang | 180 | 2014-10-01 | 2014-11-05 |
Head and Neck Neoplasms (2) · Esophageal Neoplasms (1) · Esophageal Squamous Cell Carcinoma (1)
Renmiao Zhang (1) · Sichuan University (1)
China (2)